Eterna Therapeutics (ERNA) Short Interest Ratio & Short Volume → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free ERNA Stock Alerts $2.15 0.00 (0.00%) (As of 04:21 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Eterna Therapeutics Short Interest DataCurrent Short Volume42,400 sharesPrevious Short Volume33,600 sharesChange Vs. Previous Month+26.19%Dollar Volume Sold Short$101,760.00Short Interest Ratio / Days to Cover4.4Last Record DateMarch 31, 2024Outstanding Shares5,410,000 sharesFloat Size2,980,000 sharesShort Percent of Float1.42%Today's Trading Volume3,658 sharesAverage Trading Volume9,097 sharesToday's Volume Vs. Average40% Short Selling Eterna Therapeutics ? Sign up to receive the latest short interest report for Eterna Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatERNA Short Interest Over TimeERNA Days to Cover Over TimeERNA Percentage of Float Shorted Over Time Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Eterna Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202442,400 shares $101,760.00 +26.2%1.4%4.4 $2.40 3/15/202433,600 shares $73,248.00 -11.1%1.1%2.7 $2.18 2/29/202437,800 shares $58,968.00 -74.3%1.3%1.6 $1.56 2/15/2024146,800 shares $233,412.00 -0.7%4.9%4.8 $1.59 1/31/2024147,900 shares $246,993.00 +11.7%5.0%4.6 $1.67 1/15/2024132,400 shares $213,164.00 -1.2%4.4%3.7 $1.61 Get the Latest News and Ratings for ERNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023134,000 shares $240,530.00 +261.2%4.5%3.9 $1.80 12/15/202337,100 shares $56,021.00 -67.7%1.2%1.1 $1.51 11/30/2023114,700 shares $103,230.00 -7.0%3.9%4.3 $0.90 11/15/2023123,300 shares $145,494.00 +4.2%4.1%9.1 $1.18 10/31/2023118,300 shares $166,791.17 +6.6%4.0%9.5 $1.41 10/15/2023111,000 shares $238,872.00 +1.6%3.7%11.3 $2.15 9/30/2023109,300 shares $238,274.00 -16.3%3.7%9 $2.18 9/15/2023130,500 shares $315,810.00 +21.3%4.4%10.2 $2.42 8/31/2023107,600 shares $262,544.00 +9.9%3.7%8.1 $2.44 8/15/202397,900 shares $237,897.00 -6.6%3.2%3.7 $2.43 7/31/2023104,800 shares $290,296.00 -1.5%3.5%3.9 $2.77 7/15/2023106,400 shares $298,984.00 -1.4%3.6%3.9 $2.81 6/30/2023107,900 shares $239,538.00 +6.1%3.7%4.4 $2.22 6/15/2023101,700 shares $242,046.00 -22.1%3.4%4.3 $2.38 5/31/2023130,600 shares $272,954.00 +64.3%4.5%5.8 $2.09 5/15/202379,500 shares $229,755.00 No Change2.7%8.6 $2.89 ERNA Short Interest - Frequently Asked Questions What is Eterna Therapeutics' current short interest? Short interest is the volume of Eterna Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 42,400 shares of ERNA short. 1.42% of Eterna Therapeutics' shares are currently sold short. Learn More on Eterna Therapeutics' current short interest. What is a good short interest ratio for Eterna Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ERNA shares currently have a short interest ratio of 4.0. Learn More on Eterna Therapeutics's short interest ratio. Which institutional investors are shorting Eterna Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eterna Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Eterna Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.42% of Eterna Therapeutics' floating shares are currently sold short. Is Eterna Therapeutics' short interest increasing or decreasing? Eterna Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 42,400 shares, an increase of 26.2% from the previous total of 33,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eterna Therapeutics' float size? Eterna Therapeutics currently has issued a total of 5,410,000 shares. Some of Eterna Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eterna Therapeutics currently has a public float of 2,980,000 shares. How does Eterna Therapeutics' short interest compare to its competitors? 1.42% of Eterna Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Eterna Therapeutics: MIRA Pharmaceuticals, Inc. (0.71%), ABVC BioPharma, Inc. (15.21%), RedHill Biopharma Ltd. (3.07%), Benitec Biopharma Inc. (0.47%), Tonix Pharmaceuticals Holding Corp. (1.48%), Monopar Therapeutics Inc. (2.29%), Imunon, Inc. (4.75%), Purple Biotech Ltd. (0.88%), Elevai Labs, Inc. (0.19%), Guardion Health Sciences, Inc. (13.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Eterna Therapeutics stock? Short selling ERNA is an investing strategy that aims to generate trading profit from Eterna Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eterna Therapeutics? A short squeeze for Eterna Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERNA, which in turn drives the price of the stock up even further. How often is Eterna Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERNA, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: MIRA Short Squeeze ABVC Short Squeeze RDHL Short Squeeze BNTC Short Squeeze TNXP Short Squeeze MNPR Short Squeeze IMNN Short Squeeze PPBT Short Squeeze ELAB Short Squeeze GHSI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ERNA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative